Learning about global regulatory requirements and understanding the pathway for approval can help clinical development teams take their global strategy in the right direction. Sharing expertise from regulatory experts for those who need it. (This article was originally published on LinkedIn). It’s no news that we are now living in an era with tremendous surge of […]

Read More →

Rare diseases are rapidly becoming a high priority therapeutic area for our industry. This is needed, especially when fewer than 5% of approx 7,000 rare diseases have drug therapies available, and many of these provide limited benefit. There is also a business case to this, due to a supportive reimbursement environment, particularly in the US. […]

Read More →

A Complicated Urinary Tract Infection (cUTI), a severe class of UTI, one of most common infections in the world, is notorious and recognized as a menace globally. cUTI has relapsing and refractory characteristics, and is sometimes life-threatening because of patient predisposing factors as well as the recent worldwide spread of multi-drug resistant bacteria. Pyelonephritis – infections of the kidney, […]

Read More →

Conducting clinical trial feasibility is one of the first and crucial step involved in any clinical study process. Clinical trial feasibility helps in assessing the potential of investigators, country potential for conducting the trial and many more aspects involved to execute a clinical trial successfully. What is a clinical trial feasibility? Clinical trial feasibility is […]

Read More →

Approximately one third of people with Psoriasis report being diagnosed before age 20. The prevalence of the disease in childhood and adolescence ranges between 0.5% and 2%. According to the World Psoriasis Day consortium 125 million people worldwide have Psoriasis. Psoriasis affects about 6.7 million Americans and is estimated to affect 2–4% of the population […]

Read More →

Rosacea is a common chronic inflammatory skin condition that causes redness and visible blood vessels on face. It may also produce small, red, pus-filled bumps. Rosacea can be mistaken for acne, eczema, or a skin allergy. In US more than 14 million people are estimated living with Rosacea. What is Rosacea? Rosacea is a long-term […]

Read More →

Foot ulcers refer to a patch of broken down skin usually on the lower leg or feet. In diabetics, when blood sugar levels are high or fluctuate regularly, skin that would normally heal may not properly repair itself because of nerve damage. therefore start a foot ulcer. It occurs in 15% of people with diabetes, and […]

Read More →

Glomerulonephritis (GN) is a serious kidney disorder that can lead to end-stage renal disease (ESRD), other serious morbidity, or death. Worldwide, IgA Nephropathy (Berger disease) is the most common cause of GN. IgA nephropathy is a autoimmune disease and is one of the most common kidney diseases, other than those caused by diabetes or high blood […]

Read More →

Pancreatitis, inflammation of pancreas, is the leading cause of GI related hospitalizations in USA and many other countries, with a medical condition requiring emergent care. The yearly incidence of Acute Pancreatitis in the United States and western countries is approximately 70-80 new cases per 100,000 population and has increased over the last decade. In 2015, […]

Read More →

What do you call a country with quality research facilities, efficient ethics and regulatory framework, diverse participant recruitment pool, research tax incentives and flexibility in conducting research? Some call it a dream destination, others Australia! It’s a country that has the world’s best researchers and health professionals, boasts a world-class research infrastructure and high standards of […]

Read More →